A Lifesaving Antibiotic
A Lifesaving Antibiotic
In the fight against Ebola
A new International Medical Corps study has concluded that treating Ebola patients within 48 hours of admission with the antibiotic cefixime may reduce mortality among those suffering from the deadly virus.
The study, drawn from data gathered during the West African Ebola Virus Disease (EVD) outbreak in 2014–2015, involved 360 patients diagnosed with the virus. The results found that the mortality rate among patients given the antibiotic fell to just more than half—54.7%, compared to a death rate of more than 73% among those who did not receive the drug.